Novalis Biotech — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Rarity Bioscienceraritybioscience.cominJun 2024
Rarity Bioscience develops superRCA, a molecular detection technology that identifies DNA mutations with exceptional sensitivity for precision medicine applications.
BiotechDeep TechDigital HealthHealthtechMedical DevicesUppsala, SE
Lei Chen(Co-Founder & CTO)inUlf Landegren(Co-Founder & Board Member)Per Matsson(Co-Founder & Chairman of the Board)in
Co-investorsNavigare Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.